Fragrance sells product, but it also drives some of the most complex labelling and formulation work you'll do in 2025 and beyond. Europe has expanded the list of fragrance allergens that must be named on labels when present above set thresholds, Great Britain hasn't (yet) mirrored those changes, and the U.S. is moving toward its own disclosure rule under MoCRA. Read on for a clear, practical path through the moving parts so you can plan reformulation, labelling, and artwork u

Environmental monitoring trends often look compliant until challenged. Internally, data may sit within defined alert and action limits. Deviations are opened when thresholds are crossed. Monthly review forums conclude that the cleanroom remains in control. From a governance standpoint, this appears disciplined. Inspection scrutiny often reframes that narrative entirely. What appears compliant in isolation can signal systemic weakness when assessed against regulatory expectati

Cosmetic recalls often follow long-standing weak GMP understanding. When a recall becomes public, it is usually framed as a discrete failure, a contaminated batch, a mislabelled ingredient, or an out-of-specification preservative level. The narrative suggests a recent error. In many cases, the underlying weakness has existed for years and results in real business, regulatory and consumer risks. A Stack of Regulatory Documents. The Comfort of Assumed Control Quality systems in